Among the most popular fund investment industries, there are Clinical Trials, Therapeutics. Among the various public portfolio startups of the fund, we may underline Modus Therapeutics Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Rosetta Capital, Praktikerinvest, Ostersju00f6stiftelsen. In the next rounds fund is usually obtained by HealthCap.
The fund is constantly included in less than 2 deals per year. Deals in the range of 1 - 5 millions dollars are the general things for fund. The high activity for fund was in 2017.
| Fund Name | Location |
| Active Starts | California, San Francisco, United States |
| Axis Capital | India, Maharashtra, Mumbai |
| Chip One Stop | Japan, Kanagawa Prefecture, Yokohama |
| Coagulare Biomedica | - |
| CW Group | Connecticut, Greenwich, United States |
| Fondo de Capital Privado (FCP) | - |
| Guangzhou Chuangxi Enterprise Management | China, Guangdong, Guangzhou |
| Hitachi Global Life Solutions | Japan, Shibuya |
| Jianmin Pharmaceuticals | - |
| Jincheng Boshi | Beijing, Beijing, China |
| Menomadin Foundation | - |
| MRCF Biomedical Translation Fund | - |
| OTB Ventures | Amsterdam, Noord-Holland, The Netherlands |
| Perpetual Ventures | - |
| Rosebud Fund | - |
| SZZT Electronics | China, Guangdong Province, Huizhou |
| Tairui Investment | - |
| Tianma Bearing Group | China, Guangdong, Huzhou |
| Western Life Sciences Venture Fund | Canada, Manitoba, Winnipeg |
| Wonderful Sky Financial Group | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 